Erste Asset Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-18,000
| Closed | -$102K | – | 560 |
|
|
2024
Q3 | $102K | Hold |
18,000
| – | – | ﹤0.01% | 495 |
|
|
2024
Q2 | $77.2K | Hold |
18,000
| – | – | ﹤0.01% | 498 |
|
|
2024
Q1 | $91.1K | Hold |
18,000
| – | – | ﹤0.01% | 493 |
|
|
2023
Q4 | $173K | Hold |
18,000
| – | – | ﹤0.01% | 486 |
|
|
2023
Q3 | $121K | Hold |
18,000
| – | – | ﹤0.01% | 496 |
|
|
2023
Q2 | $142K | Hold |
18,000
| – | – | ﹤0.01% | 507 |
|
|
2023
Q1 | $150K | Hold |
18,000
| – | – | ﹤0.01% | 514 |
|
|
2022
Q4 | $164K | Hold |
18,000
| – | – | ﹤0.01% | 512 |
|
|
2022
Q3 | $176K | Hold |
18,000
| – | – | ﹤0.01% | 504 |
|
|
2022
Q2 | $178K | Hold |
18,000
| – | – | ﹤0.01% | 517 |
|
|
2022
Q1 | $221K | Buy |
+18,000
| New | +$221K | ﹤0.01% | 500 |
|